Syndax Reports Third Quarter 2024 Financial Results and Provides Business Update
Press Releases
Syndax Pharmaceuticals, Inc.  
November 5, 2024

Syndax Reports Third Quarter 2024 Financial Results and Provides Business Update

– New revumenib and Niktimvo™ clinical data will be highlighted at 66th ASH Annual Meeting –

logo salamanca press

Salamanca Press

Local & Social